Roivant Sciences
Karen Jay is an experienced finance professional with a robust background in investment analysis and management. Currently serving as Director at Roivant Sciences, Karen has previously held analyst positions at Tareo Capital and Fred Alger Management, where analytical skills were developed and honed. Additionally, Karen has gained significant experience as a Vice President at JP Morgan, showcasing a strong progression in the finance sector.
This person is not in the org chart
This person is not in any teams
Roivant Sciences
56 followers
Roivant Sciences is a biopharmaceutical company focused on realizing the full value of promising drug candidates to improve the lives of patients.